Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®
Authors:
- Cécile ConteCCCécile Conte
- Francois MontastrucFMFrancois Montastruc
- Maryse Lapeyre-MestreMLMaryse Lapeyre-Mestre
- Fabien DespasFDFabien Despas
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cutaneous adverse effects of targeted therapiesJournal of the American Academy of Dermatology, 2015
- Dermatologic Adverse Events to Targeted Therapies in Lower GI Cancers: Clinical Presentation and ManagementCurrent Treatment Options in Oncology, 2013
- Understanding, recognizing, and managing toxicities of targeted anticancer therapiesCA: A Cancer Journal for Clinicians, 2013
- Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral ClinicAmerican Journal of Clinical Dermatology, 2013
- The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer DrugsJournal of Clinical Oncology, 2012
- Physical and psychosocial impact of acne in adult femalesIndian Journal of Dermatology, 2012
- Comprehensive analysis of kinase inhibitor selectivityNature Biotechnology, 2011
- Dermatologic manifestations of cytotoxic therapyDermatologic Therapy, 2011
- Mechanisms of cutaneous toxicities to EGFR inhibitorsNature Reviews Cancer, 2006
- The Protein Kinase Complement of the Human GenomeScience, 2002